JUL 10, 2018 04:10 PM PDT

Reducing Cholesterol with Gene Editing

WRITTEN BY: Carmen Leitch

Scientists know that there is a link between a protein called PCSK9 and cholesterol; when the protein is not active, cholesterol levels go down. Therapies that aim to use this relationship to the patient’s advantage have focused on inhibiting drugs. A new study has used gene editing to inactivate the protein in rhesus macaque monkeys; the researchers were able to successfully lower cholesterol levels in those monkeys. This work, reported in Nature Biotechnology, may open up new approaches for treating patients with heart disease that cannot take PCSK9 inhibitors, which are often used to control high cholesterol.

Pictured is a cholesterol-filled atherosclerotic coronary artery from a human body. /Credit: Courtesy: University of Pennsylvania School of Medicine

In healthy people, PCSK9 can stop receptors from taking up excess bad cholesterol, called LDL, in the liver. It’s been found that drugs that inhibit the PCSK9 protein can lower cholesterol in people. However, some people with a severe type of cardiovascular disease called hypercholesterolemia cannot take these drugs. This research has shown that gene editing may be helpful for these cases.

"Most often these patients are treated with repeated injections of an antibody to PCSK9," noted first author Lili Wang, Ph.D., a research associate professor of Medicine. "But, our study shows that with successful genome editing, patients who cannot tolerate inhibitor drugs might no longer need this type of repeat treatment."

A Durham, NC biotech called Precision Biosciences coauthored this work. They created an enzyme that could recognize PCSK9, and inactivate it. The enzyme, called a meganuclease, was used along with a molecular tool called an adeno-associated virus (AAV) to target the therapeutics to the liver of the primate research model.

In animals that were exposed to middle- and high-dose AAV vectors, the levels of PCSK9 were reduced from 30 to 60 percent. The AAV vector that was used in this study has been shown in clinical trials to be safe and effective.

"Our initial work with several delivery and editing approaches produced the most impressive data in non-human primates when we paired AAV for delivery with the engineered meganuclease for editing," said senior author James M. Wilson, MD, Ph.D., a professor of Medicine and Pediatrics and director of the Gene Therapy Program at Penn. "We leveraged our 30-plus years of experience in gene therapy to progress the translational science of in vivo genome editing, and in doing so, reinforced the importance of early studies in nonhuman primates to assess safety and efficacy."

The researchers want to be sure that any gene edits they make in patients are limited to the PCSK9 gene. They also need to monitor for effects on the immune system. This work will hopefully help those suffering not only from hypercholesterolemia but a variety of metabolic diseases caused by gene mutations, and which affect the liver.

 

Sources: AAAS/Eurekalert! Via Penn Medicine News, Nature Biotechnology

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 15, 2019
Neuroscience
DEC 15, 2019
Rabbit Study Holds Answer for Why Women Orgasm
Despite our increasing knowledge of the human brain, evolution and general biological processes, one thing has remained a mystery: why females orgasm. Now,...
DEC 15, 2019
Genetics & Genomics
DEC 15, 2019
The Risk of Developing PTSD is Influenced by Genetics
It's been estimated that 6 to 9% of Americans experience a trauma that results in post-traumatic stress disorder in their lifetime....
DEC 15, 2019
Cancer
DEC 15, 2019
Looking to the depths of the human genome to understand cancer
Have you ever heard of dark matter? No, I’m not talking about the dark matter of the universe – I mean the dark matter that lives within your g...
DEC 15, 2019
Genetics & Genomics
DEC 15, 2019
Familial Alzheimer's Gene Found to Regulate Nerve Development
An international team of scientists has now identified a process that plays a critical role in the growth of one part of neurons, the axon....
DEC 15, 2019
Genetics & Genomics
DEC 15, 2019
A Way to Predict Which Microbes Can Cause Cancer
Researchers have created a technique that can identify bacteria and viruses that are linked to cancer....
DEC 15, 2019
Genetics & Genomics
DEC 15, 2019
Researchers Rewire E. coli to Consume Carbon Dioxide
Milo et. al.   Researchers have genetically rewired the metabolism of Escherichia coli to be autotrophic, using formate (COOH) as a food sou...
Loading Comments...